Restricted Substances in Manufacturing Process

GECA·clause MS-2.5·p.22

The requirement

The publisher’s words are shown on request, below the limits.

The publisher’s words

The publisher lets each reader see 4 of this document’s clauses a day.

This is the publisher’s condition for Klar Cite showing its words; the limits, the citation and everything else on this page are free to read. Showing the wording counts one clause.

How it is proven

Evidence required
DoC MS-2.5.1: A schedule of the constituent chemical substances in g/kg used in the manufacture of the product that are classified as harmful, and relevant SDS; DoC MS-2.5.2: A signed declaration from an Executive Director of the applicant (or manufacturing) company stating that the above compounds, their functional derivatives or in-situ precursors are not added to finished products, their component parts or be used at any stage of the manufacturing process, including as preparatory agents, cleaners or degreasers in the production facility.
Who checks it
Independent body verifies — a certifier, auditor or verifier with no stake

How Klar Cite classifies it

Klar Cite’s reading of the clause, not the scheme’s own claim.

What it asks
Disclose — information the applicant must provide
Standing
Required — must be met for the credential
Impact area
Human Health — the CMF area the clause addresses

Cite this clause

GECA · Panel Boards · version PB Gen 3.0 · clause MS-2.5 · page 22 · build 2026-10-05-0439 · https://klarcite.com/r/71a2028c2724deaa

Source document

Record details

Page 22, MS-2.5 RESTRICTED SUBSTANCES IN MANUFACTURING PROCESS. Read in build 2026-10-05-0439, harvested 2026-10-05.

uid 71a2028c2724deaa · document 58ab1f45b86f0075 · fidelity verbatim · published 2026-06

Other clauses in this standard